Avior Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-37
Closed -$2.08K 1253
2024
Q4
$2.08K Sell
37
-11
-23% -$685 ﹤0.01% 2109
2024
Q3
$3.27K Buy
+48
New +$2.71K ﹤0.01% 1892
2024
Q2
Sell
-46
Closed -$3.18K 2738
2024
Q1
$3.18K Buy
46
+39
+557% +$2.47K ﹤0.01% 2192
2023
Q4
$517 Hold
7
﹤0.01% 1422
2023
Q3
$477 Hold
7
﹤0.01% 1494
2023
Q2
$657 Buy
+7
New +$546 ﹤0.01% 1440
2022
Q3
Sell
-1,126
Closed -$44K 1194
2022
Q2
$44K Hold
1,126
﹤0.01% 591
2022
Q1
$78K Hold
1,126
0.01% 537
2021
Q4
$87K Buy
+1,126
New +$99.4K 0.01% 520
2019
Q3
Sell
-2,810
Closed -$320K 803
2019
Q2
$332K Buy
+2,810
New +$283K 0.06% 273

Other funds holding EXAS

Avior Wealth Management's EXAS Position: Q1 2025 in Review

Avior Wealth Management sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 37 shares — an estimated $2.08K sold.

Avior Wealth Management first reported a position in EXAS in Q2 2019 and held it in 10 quarters. The position peaked at $332K in Q2 2019. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Avior Wealth Management reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 37 Exact Sciences shares in Q1 2025, an estimated $2.08K.
  • Avior Wealth Management first reported a position in Exact Sciences in Q2 2019 and held it in 10 quarters.
  • Avior Wealth Management's Exact Sciences position peaked at $332K in Q2 2019.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.